LeadIQ logo
Learn more at LeadIQ.com

Insights

Market Expansion Opportunity Century Therapeutics has recently acquired Clade Engineering Systems Ltd for $120M and Clade Therapeutics, Inc. for $35M, indicating a potential to expand its market presence and product portfolio.

Financial Strength With recent funding of $60M and a revenue range of $50M - 100M, Century Therapeutics showcases financial stability and growth potential, making it an attractive partner for collaborations or investments.

Strategic Talent Acquisition Century Therapeutics appointed Morgan Conn, Ph.D., as CFO and Chad Cowan, Ph.D., as CSO, demonstrating a strategic move to strengthen its leadership team and drive innovation in the biotechnology space.

Technological Advancements Utilizing a tech stack including Craft CMS, MySQL, and Webpack, Century Therapeutics shows a commitment to leveraging advanced technologies in its research and development processes, presenting opportunities for tech-oriented partnerships.

Competitive Positioning Ranked among similar companies like Atara Biotherapeutics and Orna Therapeutics in terms of revenue and employee size, Century Therapeutics positions itself as a key player in the biotechnology research industry with room for further growth and market competitiveness.

Similar companies to Century Therapeutics, Inc

Century Therapeutics, Inc Tech Stack

Century Therapeutics, Inc uses 8 technology products and services including Craft CMS, MySQL, Open Graph, and more. Explore Century Therapeutics, Inc's tech stack below.

  • Craft CMS
    Content Management System
  • MySQL
    Database
  • Open Graph
    Miscellaneous
  • Webpack
    Miscellaneous
  • X-XSS-Protection
    Security
  • Akamai Web Application Protector
    Security
  • Minitab
    Visualisation Software
  • Yii
    Web Frameworks

Media & News

Century Therapeutics, Inc's Email Address Formats

Century Therapeutics, Inc uses at least 1 format(s):
Century Therapeutics, Inc Email FormatsExamplePercentage
FLast@centurytx.comJDoe@centurytx.com
76%
First.Last@centurytx.comJohn.Doe@centurytx.com
18%
Last@centurytx.comDoe@centurytx.com
5%
First@centurytx.comJohn@centurytx.com
1%

Frequently Asked Questions

Where is Century Therapeutics, Inc's headquarters located?

Minus sign iconPlus sign icon
Century Therapeutics, Inc's main headquarters is located at 25 N 38th St 11th Floor Philadelphia, Pennsylvania 19104 US. The company has employees across 2 continents, including North AmericaEurope.

What is Century Therapeutics, Inc's stock symbol?

Minus sign iconPlus sign icon
Century Therapeutics, Inc is a publicly traded company; the company's stock symbol is IPSC.

What is Century Therapeutics, Inc's official website and social media links?

Minus sign iconPlus sign icon
Century Therapeutics, Inc's official website is centurytx.com and has social profiles on LinkedIn.

How much revenue does Century Therapeutics, Inc generate?

Minus sign iconPlus sign icon
As of September 2024, Century Therapeutics, Inc's annual revenue reached $75M.

What is Century Therapeutics, Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Century Therapeutics, Inc's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Century Therapeutics, Inc have currently?

Minus sign iconPlus sign icon
As of September 2024, Century Therapeutics, Inc has approximately 201 employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: B. P.Chief Executive Officer: O. L. F.Chief Technology And Manufacturing Officer: G. R.. Explore Century Therapeutics, Inc's employee directory with LeadIQ.

What industry does Century Therapeutics, Inc belong to?

Minus sign iconPlus sign icon
Century Therapeutics, Inc operates in the Biotechnology Research industry.

What technology does Century Therapeutics, Inc use?

Minus sign iconPlus sign icon
Century Therapeutics, Inc's tech stack includes Craft CMSMySQLOpen GraphWebpackX-XSS-ProtectionAkamai Web Application ProtectorMinitabYii.

What is Century Therapeutics, Inc's email format?

Minus sign iconPlus sign icon
Century Therapeutics, Inc's email format typically follows the pattern of . Find more Century Therapeutics, Inc email formats with LeadIQ.

How much funding has Century Therapeutics, Inc raised to date?

Minus sign iconPlus sign icon
As of September 2024, Century Therapeutics, Inc has raised $60M in funding. The last funding round occurred on Apr 11, 2024 for $60M.

When was Century Therapeutics, Inc founded?

Minus sign iconPlus sign icon
Century Therapeutics, Inc was founded in 2018.
Century Therapeutics, Inc

Century Therapeutics, Inc

Biotechnology ResearchPennsylvania, United States201-500 Employees

Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer and autoimmune disease care. 

Please note Century Therapeutics does not solicit prospective Colleagues directly via Telegram (or other social media sites), or require potential candidates to make purchases of goods or services.

Section iconCompany Overview

Headquarters
25 N 38th St 11th Floor Philadelphia, Pennsylvania 19104 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
IPSC
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $60M

    Century Therapeutics, Inc has raised a total of $60M of funding over 4 rounds. Their latest funding round was raised on Apr 11, 2024 in the amount of $60M.

  • $50M$100M

    Century Therapeutics, Inc's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $60M

    Century Therapeutics, Inc has raised a total of $60M of funding over 4 rounds. Their latest funding round was raised on Apr 11, 2024 in the amount of $60M.

  • $50M$100M

    Century Therapeutics, Inc's revenue is in the range of $50M$100M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.